A Phase I, safety, tolerability and efficacy study of topical AKP-11 administration to participants with atopic dermatitis
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2017
At a glance
- Drugs AKP 11 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Akaal Pharma
- 10 Feb 2017 Status changed from recruiting to completed.
- 09 Jun 2016 Status changed from not yet recruiting to recruiting.
- 08 Jun 2016 Status changed from planning to not yet recruiting.